Lexicon Pharmaceuticals (LXRX) Treasury Shares (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has 17 years of Treasury Shares data on file, last reported at $2.8 million in Q1 2026.

• On a quarterly basis, Treasury Shares fell 45.19% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a 45.19% decrease from a year earlier, with the FY2025 full-year figure at $5.2 million, up 12.39% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.8 million, down from $5.2 million in the prior quarter.
• Over the last five years, Treasury Shares for LXRX reached as high as $16.5 million in Q1 2025 and fell as low as $488205.0 in Q4 2022.
• Historically, Treasury Shares has averaged $8.2 million across 5 years, with a median of $5.5 million in 2023.
• Across the five-year window, Treasury Shares plunged 72.59% in 2022 and jumped 59.97% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $2.1 million in 2022, then surged by 39.98% to $2.9 million in 2023, then soared by 59.97% to $4.6 million in 2024, then climbed by 12.39% to $5.2 million in 2025, then plunged by 45.19% to $2.8 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $2.8 million in Q1 2026, $5.2 million in Q4 2025, and $5.2 million in Q3 2025.